📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. (2018)

First Author: Friedman SL

Attributed to: Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hep.29477

PubMed Identifier: 28833331

Publication URI: http://europepmc.org/abstract/MED/28833331

Type: Journal Article/Review

Volume: 67

Parent Publication: Hepatology (Baltimore, Md.)

Issue: 5

ISSN: 0270-9139